Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …

Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …

Introduction Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …

Introduction Severe pneumonia caused by multidrug-resistant Acinetobacter baumannii
(MDR-AB) remains a difficult-to-treat infection. Considering the poor lung penetration of most …

Fosfomycin is being increasingly prescribed for multidrug-resistant bacterial infections. In
patients with systemic involvement, intravenous fosfomycin is usually administered as a …

Multidrug resistant Gram-negative bacteremia represents a therapeutic challenge clinicians
have to deal with. This concern becomes more difficult when causing germs are represented …

Objectives To investigate the in vitro activity of fosfomycin, colistin and combinations thereof
against planktonic and biofilm cultures of Gram-negative pathogens, mostly showing MDR …

Pathogenic bacteria have the ability to sense their versatile environment and adapt by
behavioral changes both to the external reservoirs and the infected host, which, in response …

Abstract Aims Carbapenem‐resistant Acinetobacter baumannii represents a public health
problem, and the search for new antibacterial drugs has become a priority. Here, we …

Fruits containing antioxidants, eg, anthocyanins, exhibit antimicrobial activities. The
emergence of drug resistance represents a major challenge in eradicating H. pylori. The …